182 related articles for article (PubMed ID: 24454000)
21. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.
Ma MW; Gao XS; Gu XB; Xie M; Cui M; Zhang M; Liu L; Yin H; Chen LQ
World J Surg Oncol; 2018 Aug; 16(1):172. PubMed ID: 30119684
[TBL] [Abstract][Full Text] [Related]
22. Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
Jiang W; Verma V; Haque W; Moreno AC; Koshy M; Butler EB; Teh BS
Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31504359
[TBL] [Abstract][Full Text] [Related]
23. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
Furuta M; Yokota T; Tsushima T; Todaka A; Machida N; Hamauchi S; Yamazaki K; Fukutomi A; Kawai S; Kawabata T; Onozawa Y; Yasui H
Jpn J Clin Oncol; 2019 Oct; 49(10):910-918. PubMed ID: 31219161
[TBL] [Abstract][Full Text] [Related]
24. Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study.
van der Zijden CJ; Bouwman A; Mostert B; Nuyttens JJME; van der Sluis PC; Spaander MCW; Mens JWM; Homs MYV; van Doorn L; Wijnhoven BPL; Lagarde SM
Dis Esophagus; 2024 Jun; ():. PubMed ID: 38836354
[TBL] [Abstract][Full Text] [Related]
25. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
26. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
[TBL] [Abstract][Full Text] [Related]
28. Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.
Li W; Chen P; Zhang N; Song T; Wu S
Oncologist; 2019 Apr; 24(4):461-e136. PubMed ID: 30850562
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.
Ogawa K; Ishikawa H; Hisakura K; Hiroshima Y; Moriwaki T; Yamada T; Yamamoto Y; Akashi Y; Owada Y; Ohara Y; Enomoto T; Furuya K; Doi M; Shimomura O; Takahashi K; Hashimoto S; Sakurai H; Oda T
Int J Clin Oncol; 2021 Oct; 26(10):1856-1863. PubMed ID: 34241725
[TBL] [Abstract][Full Text] [Related]
30. Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy.
Chi D; Chen B; Guo S; Bai K; Ma H; Hu Y; Li Q; Zhu Y
Aging (Albany NY); 2021 Mar; 13(6):8408-8420. PubMed ID: 33713398
[TBL] [Abstract][Full Text] [Related]
31. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
32. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Yeom JG; Kim JH; Kim JW; Cho Y; Lee IJ; Lee CG; Chun J; Youn YH; Park H
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809157
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant Chemotherapy Improves Feasibility of Larynx Preservation and Prognosis in Resectable Locally Advanced Cervical Esophageal Cancer.
Kubo Y; Nozaki R; Igaue S; Utsunomiya D; Kubo K; Yamamoto S; Kurita D; Kashihara T; Ishiyama K; Honma Y; Oguma J; Kato K; Daiko H
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38755340
[TBL] [Abstract][Full Text] [Related]
38. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume.
Duarte MBO; Pereira EB; Lopes LR; Andreollo NA; Carvalheira JBC
JCO Glob Oncol; 2020 Jun; 6():828-836. PubMed ID: 32552112
[TBL] [Abstract][Full Text] [Related]
40. Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report.
Yura M; Koyanagi K; Hara A; Hayashi K; Tajima Y; Kaneko Y; Fujisaki H; Hirata A; Takano K; Hongo K; Yo K; Yoneyama K; Tamai Y; Dehari R; Nakagawa M
World J Clin Cases; 2021 Apr; 9(12):2801-2810. PubMed ID: 33969062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]